Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.

Fact checked by Nick Blackmer The Food and Drug Administration (FDA) on Thursday approved Journavx (suzetrigine), a new non-opioid painkiller that promises to be nonaddictive. Journavx is approved to ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

Cal Yee Farm LLC is recalling chocolate and other products. Some have been given a Class I classification by the FDA which is their highest risk level.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

Severe food sensitivities and allergies affect millions of Americans, according to the FDA. The nine "major" food allergens ...

On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...

Robert F. Kennedy Jr. also disclosed that he had reached at least one settlement agreement with a company or individual that ...

Three chocolate products have been recalled due to the presence of an undeclared allergen, the Food and Drug Administration announced.

Will prices on food, pharmaceuticals and electronics go up in Florida after President Trump's 25% tariffs on goods from ...